Shukra Pharmaceuticals Ltd.BSE: SHUKRAPHAR

Shukra Pharmaceuticals Ltd. Press Release Oct 03 2025

Oct 3, 2025 at 9:23 AM EDT · Issued by Shukra Pharmaceuticals Ltd. via BSE India

Filed with BSE · Oct 3, 2025 at 9:23 AM EDT

Preferential Issue of 46,43,000 convertible equity warrants to promoter subject to approval from shareholders.

6ix hasn’t read this filing yet.

Earlier from Shukra Pharmaceuticals

Follow Shukra Pharmaceuticals into a list and get an email when it puts out news.